Consumer Health Cancer / Immunology

Cure Brain Cancer Foundation CEO Lance Kawaguchi Triumphs in SouthPoleTrek4Cancer, Raising Over $1 Million

     Lance Kawaguchi, the dynamic CEO of Cure Brain Cancer Foundation, has achieved an extraordinary milestone by ...

 February 26, 2024 | News

BD Partners with Camtech Health to Increase Access to Cervical Cancer Screening in Singapore

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced a strategic partnership with Camtech Health, a ...

 February 22, 2024 | News

Japan Accelerates Approval Process for Groundbreaking Urothelial Cancer Treatment by Astellas

Astellas Pharma Inc. (TSE:4503, President and CEO: Naoki Okamura, "Astellas")  announced that Japan's Ministry of Health, Labour a...

 February 19, 2024 | News

Jacobio Gains China CDE Approval for Phase III SHP2 and KRAS G12C Inhibitor Trial

This approved study in China is a randomized active controlled phase III trial design to evaluate the efficacy and safety of JAB-3312 in combinat...

 February 19, 2024 | News

AstraZeneca's TAGRISSO® (osimertinib) with Chemotherapy Approved in the US for EGFR-Mutated Advanced Lung Cancer

AstraZeneca’s TAGRISSO® (osimertinib) with the addition of chemotherapy has been approved in the US for the treatment of adult patients with...

 February 17, 2024 | News

PharusDx Secures Exclusive License for Breakthrough Pancreatic Cancer Biomarkers from City of Hope

  Pharus Diagnostics ("PharusDx") has announced a global exclusive license agreement with City of Hope cancer center for proprietary biomarkers to be...

 February 16, 2024 | News

SOPHiA GENETICS Expands Program with AstraZeneca Spain to Enhance Access to HRD Testing Across Spain

  Originally launched in 2022, the collaboration between SOPHiA GENETICS and AstraZeneca Spain established HRD testing in five labs across the countr...

 February 08, 2024 | News

Telix to Acquire QSAM Biosciences, Bolstering Bone Cancer Targeting

  153Sm-DOTMP utilizes a cutting-edge chelating agent to deliver Samarium-153 radioisotope, offering potential advancements in bone cancer treatment....

 February 08, 2024 | News

World Cancer Day 2024: WHO Regional Director Urges Collective Action for a Cancer-Free Africa

  The cancer situation in Africa is alarming, with 1.1 million new cases and 700,000 deaths in 2020. Breast, cervical, prostate, colorectal, and live...

 February 04, 2024 | News

DELFi Diagnostics Launches Fragmentome-Based Cancer Treatment Monitoring Assay

DELFI Diagnostics, Inc., a developer of accessible blood-based tests that deliver a new way to enhance cancer detection, announced availability of the comp...

 February 04, 2024 | News

ASPIRE Consortium Tackles Rising Lung Cancer in Asia-Pacific

Lung cancer has a significant health and economic impact in the region. It is the most prevalent cancer, accounting for about 1 million deaths per year, an...

 February 04, 2024 | News

Genmab and Pfizer Announce European Medicines Agency Validation for Tisotumab Vedotin in Cervical Cancer

Genmab A/S (Nasdaq: GMAB) and Pfizer, Inc. (NYSE: PFE) have reported that the European Medicines Agency (EMA) has validated the marketing authorization app...

 February 02, 2024 | News

RemeGen Spotlights Three Major Advances in Global Cancer Battle, Closing Care Gap

Dr. Jianmin Fang, CEO of RemeGen, commented, "Cancer is the common enemy of mankind, and at RemeGen we feel a strong sense of responsibility and missi...

 February 02, 2024 | News

QIAGEN Digital Insights Introduces Rapid NGS Analysis for Somatic Cancer

New software accelerator significantly reduces time and cost of NGS secondary analysis for somatic cancer, analyzing a 275-gene comprehensive cancer pane...

 February 02, 2024 | News


Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox


Forgot your password?



Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in